RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Formosa Laboratories Stock

Formosa Laboratories Stocks 2024

Formosa Laboratories Stocks

120.49 M

Ticker

4746.TW

ISIN

TW0004746003

In 2024, Formosa Laboratories had 120.49 M outstanding stocks, a 0% change from the 120.49 M stocks in the previous year.

The Formosa Laboratories Stocks history

YEARNUMBER OF STOCKS (undefined TWD)
2025e120.49
2024e120.49
2023120.49
2022120.88
2021121.5
2020118.2
2019100.34
2018102.44
201796.43
201695.21
201595.64
201491.36
201371.7
201268.4
201167.7
201062.2
200960.4
200848.2
200736.3
200635.9

Formosa Laboratories shares outstanding

The number of shares was Formosa Laboratories in 2023 — This indicates how many shares 120.491 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Formosa Laboratories earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Formosa Laboratories's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Formosa Laboratories’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Formosa Laboratories's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Formosa Laboratories Aktienanalyse

What does Formosa Laboratories do?

Formosa Laboratories, Inc. is a renowned company in the field of research and development, pharmaceuticals, and diagnostics, operating in the industry for over 30 years. Founded in 1989, the company has become one of the leading providers of innovative solutions and products that allow its customers to improve their healthcare and enhance their quality of life. The business model of Formosa Laboratories is focused on meeting the high demands of its customers. The company works closely with medical professionals, scientists, and researchers to develop products that meet the needs of patients. With an experienced and diverse team of experts in areas such as research and development, quality control, production, marketing, and sales, Formosa Laboratories is able to offer fast and effective solutions for all customer requirements. The company has divided its various business areas into different divisions, each specialized in different areas of medicine and diagnostics. The three main business divisions are research and development, pharmaceuticals, and diagnostics. In the field of research and development, the company offers services such as preclinical research, biologics research, and development strategies. The company is dedicated to researching new control procedures and technologies to ensure the effectiveness of its solutions. Formosa Laboratories takes pride in its innovative research and development team, which stays up to date with the latest technology and continuously develops new products to meet the needs of its customers. In the pharmaceutical field, the company offers a wide range of prescription and non-prescription medications prescribed by doctors around the world. Formosa Laboratories relies on close collaboration with its customers to ensure that each patient receives the best possible medical care. The company is committed to manufacturing high-quality and safe medications. In the field of diagnostics, the company offers a variety of diagnostic tests and kits that allow for accurate and fast diagnosis of various diseases and conditions. With advanced technology and precise test results, Formosa Laboratories helps doctors and medical professionals make quick and accurate diagnoses to start treatment as soon as possible. Over the years, Formosa Laboratories has developed numerous products that have improved people's lives and fought against diseases. Some of the company's well-known products include: - Influenza Rapid Tests: A fast and accurate test for diagnosing the flu. - Pregnancy Test Kits: A traditional pregnancy test that is able to confirm or exclude pregnancy in a woman. - Needle-free Syringes: An innovation that allows for medication injection without a needle. In conclusion, Formosa Laboratories Inc is a significant company in the medical and diagnostics industry, dedicated to manufacturing high-quality and safe products. With its experienced and qualified team, the company is able to offer fast and effective solutions tailored to the individual needs of its customers. Formosa Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Formosa Laboratories's Shares Outstanding

Formosa Laboratories's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Formosa Laboratories’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Formosa Laboratories’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Formosa Laboratories’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Formosa Laboratories stock

How many stocks are there of Formosa Laboratories?

The current number of stocks of Formosa Laboratories is 120.49 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Formosa Laboratories are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Formosa Laboratories evolved in recent years?

The number of shares of Formosa Laboratories has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Formosa Laboratories as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Formosa Laboratories?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Formosa Laboratories pay?

Over the past 12 months, Formosa Laboratories paid a dividend of 1 TWD . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Formosa Laboratories is expected to pay a dividend of 0.99 TWD.

What is the dividend yield of Formosa Laboratories?

The current dividend yield of Formosa Laboratories is 1.01 %.

When does Formosa Laboratories pay dividends?

Formosa Laboratories pays a quarterly dividend. This is distributed in the months of September, August, September, September.

How secure is the dividend of Formosa Laboratories?

Formosa Laboratories paid dividends every year for the past 4 years.

What is the dividend of Formosa Laboratories?

For the upcoming 12 months, dividends amounting to 0.99 TWD are expected. This corresponds to a dividend yield of 1 %.

In which sector is Formosa Laboratories located?

Formosa Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Formosa Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Formosa Laboratories from 9/12/2024 amounting to 2 TWD, you needed to have the stock in your portfolio before the ex-date on 8/13/2024.

When did Formosa Laboratories pay the last dividend?

The last dividend was paid out on 9/12/2024.

What was the dividend of Formosa Laboratories in the year 2023?

In the year 2023, Formosa Laboratories distributed 2 TWD as dividends.

In which currency does Formosa Laboratories pay out the dividend?

The dividends of Formosa Laboratories are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Formosa Laboratories

Our stock analysis for Formosa Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Formosa Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.